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Background: Clinical Commissioning Groups (CCGs) are mandated to use research evidence effectively to ensure
optimum use of resources by the National Health Service (NHS), both in accelerating innovation and in stopping
the use of less effective practices and models of service delivery. We intend to evaluate whether access to a
demand-led evidence service improves uptake and use of research evidence by NHS commissioners compared with
less intensive and less targeted alternatives.
Methods/design: This is a controlled before and after study involving CCGs in the North of England. Participating
CCGs will receive one of three interventions to support the use of research evidence in their decision-making:
1) consulting plus responsive push of tailored evidence; 2) consulting plus an unsolicited push of non-tailored
evidence; or 3) standard service unsolicited push of non-tailored evidence. Our primary outcome will be changed at
12 months from baseline of a CCGs ability to acquire, assess, adapt and apply research evidence to support
decision-making. Secondary outcomes will measure individual clinical leads and managers’ intentions to use research
evidence in decision making. Documentary evidence of the use of the outputs of the service will be sought. A process
evaluation will evaluate the nature and success of the interactions both within the sites and between commissioners
and researchers delivering the service.
Discussion: The proposed research will generate new knowledge of direct relevance and value to the NHS. The
findings will help to clarify which elements of the service are of value in promoting the use of research evidence.
Those involved in NHS commissioning will be able to use the results to inform how best to build the infrastructure
they need to acquire, assess, adapt and apply research evidence to support decision-making and to fulfil their statutory
duties under the Health and Social Care Act.Background
The National Health Service (NHS) in England is facing
severe funding constraints both now and in the medium
term. The forecast reduction in resources will place con-
siderable pressures on its organisations and staff. In
challenging times, it has been proposed that the greatest
potential savings may be found by increasing efficiency
and reducing variations in clinical practices [1]. To do* Correspondence: paul.wilson@mbs.ac.uk
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be fully aware of the strength of the underlying evidence
for interventions or ways of working that promise to de-
liver more value from the finite resources available [2].
The 2012 Health and Social Care Act has brought
about a major shift in the commissioning landscape in
England [3]. The Act has mandated the national and
local entities, NHS England and Clinical Commissioning
Groups (CCGs) to promote ‘the use of evidence obtained
from research’.
Traditionally, public health specialists have sup-
ported and facilitated the use of research evidence in aThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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authorities, this constituency now has a more limited role in
commissioning. The responsibility for developing the absorp-
tive capacity [6,7] of CCGs to recognise and understand valu-
able research based knowledge is less clear.
Significant investment has been made in the production
of research on the effectiveness and cost effectiveness of
interventions to inform decisions and choices. An initia-
tive aiming to enhance uptake of this knowledge to in-
crease efficiency, reduce practice variations and to ensure
best use of finite resources was developed as part of the
National Institute for Healthcare Research (NIHR) Collab-
oration for Leadership in Applied Health Research and
Care for Leeds, York and Bradford [8] The service works
with local NHS commissioners and senior managers in
provider Trusts to provide research-based answers to
questions they raise. The service summarises and trans-
lates existing sources of synthesised, quality-assessed
evidence (primarily systematic reviews and economic
evaluations) to the local context. Topics addressed have
included evidence to inform service reorganisation for
adolescents with eating disorders [9], to support nurse/
doctor role substitution and the introduction of inte-
grated care pathways in mental health settings [10].
The service approach is both consultative [11] and re-
sponsive and operationalises a methodological framework
[12] that involves clarifying the problem and framing the
question to be addressed. The evidence briefings gener-
ated as part of this process summarise the quality and the
strength of existing systematic reviews and economic eval-
uations but go beyond effectiveness and cost effectiveness
to consider local applicability, implications relating to ser-
vice delivery, resource use, implementation and equity.
A key feature of the service has been interaction and
regular contact (face to face and email) between researchers
and a range of clinicians, commissioners and NHS man-
gers to discuss and formulate questions that require a
more considered response and to then produce briefings
and discuss their implications. Although feedback has
been uniformly positive to date, this service is develop-
mental and has yet to be formally evaluated.
Interactions between researchers and NHS managers
might be expected to facilitate the ongoing use of re-
search knowledge in decision-making [13-17]. How best
to do this [18] and the time and resource costs required
for both sides are less clear. What is clear is that the bene-
fit of interactions between managers and researchers is
theoretically grounded. Specifically, ongoing, positive in-
tergroup contact [19] can be effective at generating posi-
tive relations between the members of two parties where
there is institutional support, where there is equal status
between those involved, and where there is cooperation in
order to achieve a common goal [20]. Contact has most
benefit if those involved identify both with their owngroup (e.g. researchers or managers) and the overarching
organisation to which they both belong [21].
Given the resource-intensive nature of the evidence
briefing service, we need to establish how much value is
added by additional support from researchers over alter-
native or more basic dissemination approaches. A recent
systematic review described resources aimed at making
the results of systematic reviews more accessible to health-
care decision-makers [22]. A variety of resources were
identified but few were evaluated, giving little insight into
their impact on decision-making. As such, this study aims
to add insight by evaluating the impact of a real-time, con-
sultative knowledge translation service provided by re-




Does access to a demand-led knowledge translation
service improve uptake and use of research evidence by
NHS commissioners compared with less intensive and
less targeted alternatives?
Secondary research questions
Do evidence briefings (summaries of synthesised research
evidence with additional contextual information and
implications for decision-making) tailored to specific
local contexts inform decision-making in other CCGs?
Does contact between researchers and NHS
commissioners increase use of research evidence?
Setting and participants
CCGs from one geographical area in the North of England
will be contacted and told the nature of the study and
then invited to participate. We have deliberately opted to
conduct the study in a geographical area not contami-
nated by either our own earlier developmental work or
other Collaboration for Leadership in Applied Health
Research and Care (CLAHRC) related activity. Those
CCGs that agree to participate will be asked to provide
details of all governing body and executive members,
clinical leads and any other individuals deemed as being
involved in commissioning decision-making processes.
These individuals will then be contacted by the evaluation
team, told the purpose of the study and then invited to
complete baseline and follow-up assessments. We antici-
pate each intervention arm will include at least two CCGs.
Baseline and follow-up assessment
We will collect data for two outcome measures at base-
line and post-intervention, after the 12-month interven-
tion period has been completed.
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four sets of information. Section A is based on a tool
originally devised by the Canadian Health Services
Research Foundation [23,24] and then modified by the
SUPPORT Collaboration [25]. This section assesses the
organisations’ ability to acquire, assess, adapt and apply
research evidence to support decision-making. Section B
is a modified version of a tool [26,27] based on the the-
ory of planned behaviour [28]. This will measure the in-
tentions of individual CCG staff to use research evidence
in their decision-making.
Section C is designed to evaluate the changes to the
nature of the (proposed) interactions, both within the
participating sites and between commissioners and re-
searchers. Participants will be asked how much contact
they have had with researchers in their job (quantity),
and the success of the interaction (quality), using an
existing modified measure [29]. This section will also in-
clude questions regarding the extent to which the inter-
actions were perceived as friendly and cooperative, as
helping to achieve the goals of both managers and re-
searchers. The extent to which those involved in the
interaction is perceived as being on an equal footing,
without either group dominating, and the extent to
which the contact is perceived as being supported by the
CCGs, and the NHS more generally, will also be exam-
ined. Participants will also be asked to indicate the ex-
tent to which their status as an NHS manager/lead is
important to them (in-group identification) and to what
extent they see themselves and researchers as part of
one overarching group committed to achieving the same
things (superordinate identification). In addition, we will
include measures of perceptions of researchers in gen-
eral using a generalised intergroup attitude scale [30].
Section D captures information on individual respond-
ent characteristics (for example, previous experience of
doing research and self-reported uptake of new ideas)
will be collected to help us to understand variation in
responses.
Individual responses from each CCG will complete the
survey and scores of all responses will be aggregated to
represent each participating CCG. We will also be inter-
ested in variation in scores within each CCG.
A second survey based on Section A will be used to
collect data from all English CCGs. This will include
only the first outcome measure, and this will be deliv-
ered at baseline and then again post-intervention. As
CCGs are new and evolving entities, we need to be able
to determine if any changes viewed from baseline are
linked to the intervention(s) and are not just a conse-
quence of the development of the CCG(s) over the
course of the study. To guard against this maturation
bias, and to test the generalizability of findings, we will
administer the Canadian Health Services ResearchFoundation (CHSRF) instrument to all English CCGs to
assess their organisational ability to acquire, assess,
adapt and apply research evidence to support decision-
making. The most senior manager (chief operating officer
or chief clinical officer) of each CCG will be contacted
and asked to complete the CHSRF instrument on behalf
of their organisation.
Both survey instruments will be sent by email to iden-
tified participants via an embedded URL. The online
questionnaire will be hosted by SurveyMonkey website
(http://www.surveymonkey.com). Reminder emails will
be sent out to non-respondents at 2 3, and 4 weeks. A
paper version of the questionnaire will also be posted
out and phone call reminders will be utilised if required.
Interventions
Participating CCGs will receive one of the three interven-
tions aimed at supporting the use of research evidence in
their decision-making: 1) consulting plus responsive push
of tailored evidence; 2) consulting plus an unsolicited push
of non-tailored evidence; or 3) ‘standard’ service unsoli-
cited push of non-tailored evidence. The intervention
phase will run from April 2014 to May 2015. The extent
to which the CCGs seek and receive the interventions on
offer will be determined by the CCGs themselves.
1) Consulting plus responsive push of tailored evidence
After initial relationship building, participating
CCGs in this arm will receive access to an evidence
briefing service provided by the Centre for Reviews
and Dissemination (CRD). The CRD team will
synthesise existing evidence together with relevant
contextual data to produce six to eight tailored
evidence briefings on specified topics. Based on
developmental work undertaken as part of the NIHR
CLAHRC for Leeds, York and Bradford, we have
resourced the project so that we can respond to six
to eight key substantive issues during the
intervention phase.
The CRD intervention team will provide regular
advice and support on how to seek solutions from
existing evidence resources, question framing and
prioritisation. Advice and support will be both
reactive and proactive and will be delivered via
telephone, email and face to face. Contact initiated
by the CRD team will be made on at least a monthly
basis and is expected to include: discussion of
progress on ongoing topics, identification of further
evidence needs and discussion of any issues around
use of evidence. The team will also be alerting to
new systematic reviews and other synthesised
evidence relevant to CCG priorities.
The intervention team will also offer to provide
training on how to acquire, assess, adapt and apply
Wilson et al. Implementation Science  (2015) 10:7 Page 4 of 7synthesised existing evidence. Sessions will be based
on the approach developed by the CRD service [12]
and will be drawn upon the Tools for Policymakers
developed by the Support Collaboration (see www.
health-policy-systems.com/). Training to be provided
will depend on the needs on the CCG participants
but is likely to cover: question framing, priority
setting, identifying and appraising systematic review
evidence, assessing uncertainty and generalizability.
2) Consulting plus an unsolicited push of non-tailored
evidence
Participating CCGs in this arm will receive the
access to regular advice and support from CRD as
those in intervention 1). However, CRD will not
produce evidence briefings tailored to the local
CCGs context and their specified decisions but will
instead disseminate the evidence briefings generated
in intervention 1) with any area-specific contextual
information removed; thus an intervention comprising
consulting plus an unsolicited push of non-tailored
evidence.
3) ‘Standard service’ unsolicited push of non-tailored
evidence
The third intervention constitutes a ‘standard service’
control arm. In this, CRD will disseminate the evidence
briefings generated in intervention 1) and any other
non-tailored briefings produced by CRD over the
intervention period; thus, an unsolicited push of
non-tailored evidence.
Analysis
Baseline and follow-up assessment will be undertaken by
a separate evaluation team. The CRD intervention team
members delivering the intervention components will be
blinded from data and analysis.
The evaluation team will use ANOVAs to examine
whether participants in the intervention conditions per-
ceive themselves as experiencing more positive contact
experiences and more positive attitude towards researchers
over time in the intervention conditions compared to the
control condition.
The primary analysis will measure the impact of study
interventions on two main outcomes at two times
points. The key dependent variable will be the perceived
organisational capacity to use research evidence, but we
will also measure the impact of interventions upon our
second outcome of reported research use. These will be
treated as continuous variables and for each we will cal-
culate the overall mean score, any sub scale means and
related standard deviations at two time points (pre- and
post-intervention) and within four case sites. Secondary
analysis will assess interactions between the intervention
received and three further continuous independent vari-
ables measuring individual demographic characteristicsand the quality and frequency of contact, upon the two
outcome measures.
For each of these variables, we will conduct a two-way
repeated measures ANOVA with two within-subject
factors (case site [as a proxy for the model of evidence
briefing service received] and time period [pre- and
post-intervention]). SPSS version 21 ‘GLM’ analysis
procedure will be used.
If data subsequently warrants more complex multivari-
ate analysis, we will explore the possibilities with a de-
partmental statistician and the scientific advisory group.
Where measures are non-normal, we will transform the
data (logarithmically) where necessary and possible.
Analysis will be undertaken using SPSS (version 20) and
STATA statistical packages.
At follow-up, we will provide an opportunity in the
questionnaire for CCGs senior officers to provide add-
itional information that they think has changed, in their
organisation in the past 12 months. We will code the
responses to these questions thematically as well as re-
sponse/no response and enter the response as a covari-
ate in any analysis of variance conducted to examine
for systematic patterns of response amongst the vari-
able categories.
Where attrition between baseline and one-year follow-
up is an issue, multiple imputation (MI) techniques will
be employed. In addition, we will use guidance on inter-
preting effect sizes in before and after studies to examine
the significance of any changes [31].
Documentary evidence of the use of research in
decision-making
We aim to identify and understand the ways in which re-
search evidence is employed by each organisation through
analysis of decision-making records. Selection of relevant
documents will be conducted through review of a snap-
shot (one calendar month) of all documents produced by
the CCG commissioning decision-making bodies. The
evaluation team will then identify relevant documents to
include over the course of the study. The precise nature of
the analysis will be led by the content of the documents
available; however, it is anticipated that the following
qualitative analysis will be conducted. This will explore
the integration of the evidence briefings service within
decision-making processes, how research evidence in gen-
eral is used by each organisation and how these change
over time. Using a framework approach [32] and using
NVivo software (NVivo qualitative data analysis software;
QSR International Pty Ltd. Version 10, 2012), documents
will be thematically coded to capture the ways in which
research evidence has been used in the decision-making
process. In order to identify changes in the use of evidence
over time, documents will be categorised in quarterly pe-
riods with themes being compared across time periods.
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In-depth qualitative interviews with governing and ex-
ecutive body members in participating case sites will be
conducted. These will explore perceptions of the use of
research evidence locally, their experiences of the
process of the evidence briefing service and study pro-
cesses as well as any unanticipated consequences of the
work. This will add richness and depth to our quantita-
tive measures and help us to understand the study re-
sults. The purposive sampling criteria will seek to
include CCG who have had contact with the interven-
tion team.
The framework approach [32] to analysis will again be
applied to interview data. Deductive and inductive themes
will be generated and interpreted using Atlas-TI (www.
atlasti.com) to organise and manage the data. Member
validation will be employed with all participating CCGs in
each of the local health economies. In particular, it is an-
ticipated that themes relating to the following areas will
be explored: knowledge of and perceptions of the aims
and expectations of the evidence briefing service received
by the case site; expectations of and perceived impact of
the evidence briefing service delivered in the CCG; atti-
tudes to researcher evidence and how these relate to the
evidence briefing service received; and perceptions of the
use of research evidence locally.
Data integration
This is a mixed methods study using a sequential ex-
planatory strategy. The primary point of data integration
will be the analysis stage in which themes generated by
qualitative analysis will be used to help us to understand
variation in quantitative outcomes. During this process,
data will be integrated in three ways. Firstly, interviews
will be categorised according to the intervention re-
ceived and differences in the themes generated by each
interview will be compared and contrasted across case
sites. Second, individual interviews will also be cate-
gorised according to the participant’s survey responses
to questions about relationships with researchers. Fi-
nally, themes generated by interviews will be compared
with those arising from documentary evidence to iden-
tify any conflict or consistency between local perceptions
of the use of evidence and recorded use of evidence.
Ethical and consent issues
No ethical issues are anticipated as a result of this study.
None of the interventions involves any direct risks or bur-
dens to the CCGs involved. This study has been granted
ethical permission by the Department of Health Sciences,
University of York Research Ethics Board. Appropriate
research governance approval has been obtained.
Organisational level consent granting permission to
contact staff will be obtained from each participatingCCG. Participants will have the opportunity to discuss
any aspect of the study and their involvement in it with
the research team at any stage of the study. Completion
of questionnaires by individuals will be anonymous and
other members of each CCG will not be informed of in-
dividual participation.
Informed consent will be sought from those partici-
pants approached for interview as part of the process
evaluation. Those that indicate that they are not willing
to be interviewed will be deemed not to have given their
consent. For those participants that indicate that they
are willing to be interviewed, we will send written con-
firmation of the arrangements and at this point, ask inter-
viewees to provide written confirmation of their consent
to participate.
Discussion
The study has the potential to benefit NHS organisations
by helping them make better use of existing synthesised
research evidence to support their decision-making. This
research is timely because of the current and future need
to use research evidence effectively to ensure optimum
use of resources by the NHS, both in accelerating
innovation and in stopping the use of less effective
practices and models of service delivery.
The research will also address the gap in translation of
evidence into NHS practice identified in the Cooksey report
[33] and the need for accelerated innovation highlighted by
the Carruthers report [34]. The intervention phase of the
research will generate new knowledge of direct relevance
and value to CCGs. The service could result in more rapid
decisions to adopt new treatments or models of service
delivery; greater transparency of decision-making; and effi-
ciency gains generated by evidence-informed decisions to
disinvest existing services in favour of more cost-effective
alternatives.
We have adopted a pragmatic comparative mixed methods
research design (combining positivism and interpretivism).
The approach will enable triangulation of data and add a
depth of understanding to the impact of the service being
offered. Whilst details of the underlying context and spe-
cific decisions may vary, findings about the impact of the
demand-led service are likely to be broadly generalizable
to other similar decision-making bodies.
The study should help to clarify which elements of the
service are of value in promoting the use of research evi-
dence and are worth pursuing further. For example, if the
interaction and synthesis elements of the delivery model
prove to have value, there is potential for developing a
standardised service on a more expanded basis. This in
turn will present opportunities for evaluations that utilise
more robust designs or that seek to explore the service de-
livery setting and or its applicability in other geographical
jurisdictions.
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The proposed research addresses a problem that faces a
wide variety of health care organisations, namely how to
best build the infrastructure they need to acquire, assess,
adapt and apply research evidence to support their
decision-making. For CCGs and the NHS England, this
includes fulfilling their statutory duties under the Health
and Social Care Act 2012.
Additional file
Additional file 1: Clinical Commissioning Groups’ use of research
evidence.
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